Rheumatic diseases affect millions of people in the United States every year: Nearly 54 million have been diagnosed with arthritis; 1.5 million have a form of lupus; fibromyalgia affects an estimated 5 million adults; and scleroderma impacts an estimated 300,000.
To learn more about these conditions and what can be done to treat them, 150 rheumatology patients and their families gathered at the sixth annual USC Rheumatology Community Seminar. Sponsored by Amgen and Genentech and held in April at the Mayer Auditorium on USC’s Health Sciences Campus, the event gave attendees a chance to share their insights and experiences with rheumatic diseases and obtain information from physicians at the Keck School of Medicine of USC.
The day included several panels, including:
• “Current Treatments for Arthritis and Gout” (overseen by Glenn Ehresmann, associate professor of medicine at the Keck School);
• “Innate and Adaptive Immunity: Scleroderma” and “Fibromyalgia: Unraveling the Mystery” (Daniel Arkfeld, associate professor of clinical medicine at the Keck School and director of rheumatological education at Keck Hospital of USC);
• “Ankylosing Spondylitis and Psoriatic Arthritis and Their Symptoms” (Stratos Christianakis, assistant professor of clinical medicine at the Keck School); and
• “Living With Lupus” (Elizabeth Ortiz, assistant professor of clinical medicine at the Keck School).
In addition, selected rheumatology patients answered questions and told their personal stories during a “Living With My Disease” panel.
For more information about how to participate in next year’s seminar, contact Paulette Pasciuti at (323) 442-1757.